Adam Schayowitz
Insider Reports History
- Location
- Vancouver
- Signature
- /s/ Catherine Graham, Attorney-in-Fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Adam Schayowitz:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Zymeworks Inc. | EVP, Head of Research & Development | Performance Stock Unit | 76,000 | 09 Apr 2026 | Direct | ||
| Zymeworks Inc. | EVP, Head of Research & Development | Stock Option (Right to Buy) | 70,000 | 09 Apr 2026 | Direct | ||
| Zymeworks Inc. | EVP, Head of Research & Development | Restricted Stock Unit | 47,000 | 09 Apr 2026 | Direct | ||
| Zymeworks Inc. | EVP, Head of Research & Development | No securities are beneficially owned | 0 | 09 Apr 2026 | Direct |
Insider Reports Filed by Adam Schayowitz
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ZYME | Zymeworks Inc. | 09 Apr 2026 | 3 | $0 | 4 | EVP, Head of Research & Development | 10 Apr 2026, 16:10 |
| ZYME | Zymeworks Inc. | 09 Apr 2026 | 0 | $0 | 3 | Exhibit List - Exhibit 24 - Power of Attorney EVP, Head of Research & Development | 10 Apr 2026, 16:05 |